ANALISIS KADAR ASAM URAT PADA PASIEN KARSINOMA MAMMA  

Oleh:

Sevianty, Susi ; Bahrun, Uleng ; Arif, Mansyur

Jenis: Article from Journal - ilmiah nasional - terakreditasi DIKTI
Dalam koleksi: Indonesian Journal of Clinical Pathology and Medical Laboratory vol. 16 no. 01 (Nov. 2009), page 14-16.
Topik: carcinoma mammae; uric acid

Ketersediaan

Perpustakaan FK Nomor Panggil: I01.K.02 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

In malignancy cases, an increase of uric acid level is often observed after therapy (Tumor Lysis Syndrome), but some studies also indicated an increase before therapy which is related to a refusal reaction against tumor, and specific only for certain malignancy cases, Carsinoma mammae is the second most common malignancy among women in Indonesia, so that studying the phenomenon occurred in carcinoma mammae including uric acid level are expected to provide insight in management of carcinoma mammae. A longitudinal study was conducted by collecting secondary data from medical record of carcinoma mammae patients in Wahidin Sudirohusodo Hospital for period of July 2007-June 2008. Data were analyzed by using Wilcoxon Signed Rank Test with alpha 0.05. 12 of subjects are considered eligible for study criteria, with the age ranging from 28-60 years old. In generally, uric acid level determined before and after chemotherapy showed a level in normal range, except for 3 samples before therapy and 3 different samples after therapy showed a level more than 5.7 mg/dl. Statistic result showed mean uric acid level before chemotherapy was 4.508 ± 1.2566 mg/dl and after chemotherapy was 5.025 ± 1.3240 mg/dl (p = 0.16). Increased of uric acid level is not significant level was found in serum of carcinoma mammae before and after chemotherapy.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali